Abstract：[Abstract]Objective To investigate the clinical effect of Spironolactone combined with Carvedilol in the treatment of refractory hypertension.Methods A total of 80 patients with refractory hypertension admitted in our hospital from January 2017 to August 2018 were selected as the subjects,and randomly divided into routine group (n=40)and study group (n=40).Carvedilol was used in routine group.The study group was treated with Carvedilol combined with Spironolactone.The blood pressure,echocardiography and clinical efficacy were compared between the two groups.Results After treatment,the blood pressure of the two groups were significantly lower than those of the conventional group,and the blood pressure of the study group were significantly lower than that of the conventional group,with statistically significant differences(P<0.05).After treatment,the left ventricular ejection fraction of the two groups was higher than that before treatment,and the left ventricular ejection fraction of the study group was higher than that of the conventional group,with statistically significant differences(P<0.05).After treatment,the inner diameter at the end of left ventricular contraction was smaller than that before treatment in both groups,and the inner diameter at the end of left ventricular contraction in the study group was smaller than that of the conventional group,with statistically significant differences (P<0.05).The total effective rate of the study group was significantly higher than that of the conventional group (P<0.05).The total incidence of adverse reactions in the study group was lower than that in the conventional group,and the difference was statistically significant(P<0.05).Conclusion Spironolactone combined with Carvedilol is effective in the treatment of refractory hypertension.It can not only improve the blood pressure and echocardiographic parameters,but also reduce the incidence of adverse reactions.It is worth popularizing in this area.
京公网安备 11010502046607号